Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Johannesson

Showing results (81-90 of 154) with videos related to

Pageof 16
Sort By:
Current Topics in Microbiology and Immunology|May 27, 2006
Genetics of autoimmune diseases: a multistep processM Johannesson, M Hultqvist, R Holmdahl
International Journal of Technology Assessment in Health Care|October 22, 1998
A note on confidence intervals in cost-effectiveness analysisM Tambour, N Zethraeus, M Johannesson
Health Economics|February 18, 1998
Contingent valuation with an open-ended follow-up question: a test of scope effectsB Kartman, N O Stålhammar, M Johannesson
Drugs & Aging|February 1, 1996
Use of misoprostol in the elderly: is the expense justified?G Stucki, M Johannesson, M H Liang
Pharmacoeconomics|August 6, 1993
Drug expenditure and new drug introductions: the Swedish experienceU G Gerdtham, M Johannesson, B Jönsson
Laeknabladid|August 12, 2009
[Elective splenectomies in Landspítalinn 1985-1994.]S Gunnlaugsson, G M Johannesson, J Magnusson
Pharmacoeconomics|April 8, 1992
Economic evaluation of drug therapy: a review of the contingent valuation methodM Johannesson, P O Johansson, B Jönsson
Health Economics|November 1, 1996
Valuation of health changes with the contingent valuation method: a test of scope and question order effectsB Kartman, N O Stålhammar, M Johannesson
Journal of Health Economics|September 4, 1998
Time spent on waiting lists for medical care: an insurance approachM Johannesson, P O Johansson, T Söderqvist
Lakartidningen|February 7, 1998
[The 4S study is analysed. Cholesterol reduction is cost-efficient]B Jönsson, M Johannesson, A G Olsson
Pageof 16

Showing results (81-90 of 154) with videos related to

Sort By:
Pageof 16
Current Topics in Microbiology and Immunology|May 27, 2006
Genetics of autoimmune diseases: a multistep processM Johannesson, M Hultqvist, R Holmdahl
International Journal of Technology Assessment in Health Care|October 22, 1998
A note on confidence intervals in cost-effectiveness analysisM Tambour, N Zethraeus, M Johannesson
Health Economics|February 18, 1998
Contingent valuation with an open-ended follow-up question: a test of scope effectsB Kartman, N O Stålhammar, M Johannesson
Drugs & Aging|February 1, 1996
Use of misoprostol in the elderly: is the expense justified?G Stucki, M Johannesson, M H Liang
Pharmacoeconomics|August 6, 1993
Drug expenditure and new drug introductions: the Swedish experienceU G Gerdtham, M Johannesson, B Jönsson
Laeknabladid|August 12, 2009
[Elective splenectomies in Landspítalinn 1985-1994.]S Gunnlaugsson, G M Johannesson, J Magnusson
Pharmacoeconomics|April 8, 1992
Economic evaluation of drug therapy: a review of the contingent valuation methodM Johannesson, P O Johansson, B Jönsson
Health Economics|November 1, 1996
Valuation of health changes with the contingent valuation method: a test of scope and question order effectsB Kartman, N O Stålhammar, M Johannesson
Journal of Health Economics|September 4, 1998
Time spent on waiting lists for medical care: an insurance approachM Johannesson, P O Johansson, T Söderqvist
Lakartidningen|February 7, 1998
[The 4S study is analysed. Cholesterol reduction is cost-efficient]B Jönsson, M Johannesson, A G Olsson
Pageof 16